Open AccessThe DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain
Author(s) -
Darko Bosnakovski,
Erik A. Toso,
Lynn M. Hartweck,
Alessandro Magli,
Heather A. Lee,
Eliza R. Thompson,
Abhijit Dandapat,
Rita C.R. Perlingeiro,
Michael Kyba
Publication year - 2017
Publication title -
journal of cell science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.384
H-Index - 278
eISSN - 1477-9137
pISSN - 0021-9533
DOI - 10.1242/jcs.205427
Subject(s) - myod , homeobox , biology , pax3 , myogenesis , c2c12 , phenotype , microbiology and biotechnology , leucine zipper , cellular differentiation , transcription factor , cancer research , genetics , gene , myocyte
Facioscapulohumeral muscular dystrophy (FSHD) is caused by inappropriate expression of the double homeodomain protein, DUX4. DUX4 has bimodal effects, inhibiting myogenic differentiation and blocking MyoD at low levels of expression, and killing myoblasts at high levels. Pax3 and Pax7, which contain related homeodomains, antagonize the cell death phenotype of DUX4 in C2C12 cells, suggesting some type of competitive interaction. Here, we show that effects on differentiation and MyoD expression require the homeodomains but do not require the C-terminal activation domain of DUX4. We test the set of equally related homeodomain proteins; Pax6, Pitx2c, OTX1, Rax, Hesx1, MIXL1 and Tbx1; and find that only Pax3 and Pax7 display phenotypic competition. Domain analysis on Pax3 reveals that the Pax3 homeodomain is necessary for phenotypic competition, but not sufficient; competition also required the paired and transcriptional activation domains of Pax3. Remarkably, substitution mutants in which DUX4 homeodomains are replaced by Pax7 homeodomains retain the ability to inhibit differentiation and to induce cytotoxicity.